BRICS Solution Awards

Acarbose Encapsulation in Guar Gum Nanoparticles for Enhanced Anti-Diabetic Activity

Problem and implemented solution

Problem: Acarbose, an anti-diabetic drug, suffers from poor bioavailability and requires high doses to achieve therapeutic effects, often leading to gastrointestinal side effects. This limits its efficacy and patient compliance. Implemented Solution: The encapsulation of Acarbose in Guar Gum nanoparticles aims to improve its bioavailability, enhance its therapeutic effects, and reduce side effects. Guar Gum, a natural polysaccharide, offers biocompatibility and controlled release properties, making it an ideal carrier for Acarbose. The nanoparticles are designed to protect Acarbose from degradation, ensuring its gradual release and sustained anti-diabetic activity.

India
Nomination

Biotechnology And National Health

Topic

Technologies for human health

Estimated duration of implementation

The estimated duration for full implementation, including research, clinical trials, regulatory approval, and market launch, is approximately 5-7 years.

Implementation geography

ilot studies and initial commercialization will focus on urban centers with high prevalence of Type 2 diabetes

Description of competitive advantages

Enhanced Bioavailability: Improved absorption and sustained release of Acarbose, leading to better glycemic control. Reduced Side Effects: Lower doses required to achieve therapeutic effects, minimizing gastrointestinal discomfort. Biocompatibility: Use of Guar Gum, a natural and safe polysaccharide, ensures minimal toxicity. Controlled Release: Nanoparticle encapsulation allows for the controlled release of Acarbose, providing consistent therapeutic levels over time. Patient Compliance: Improved efficacy and reduced side effects lead to higher patient adherence to treatment.

List of awards and prizes, media articles about the organization/individual or the Practice

The complete list of publication can be observed at https://pubmed.ncbi.nlm.nih.gov/?term=Jeena+Gupta&sort=date and https://scholar.google.com/citations?hl=en&user=rD28XZwAAAAJ&view_op=list_works&sortby=pubdate

List of scientific works and IP connected with the Practice

Guar gum-based nanoformulations: Implications for improving drug delivery. Garg SS, Gupta J. Int J Biol Macromol. 2023 Feb 28;229:476-485. doi: 10.1016/j.ijbiomac.2022.12.271.

Contacts

For queries about BRICS Solutions Awards please reach out to Agency for Strategic Initiatives International Office Team:

Partners

logo-ntilogo-tpprflogo-brics-businesslogo-tv-bricslogo-development-corporation
rainbow
footer-star